Structural and redox requirements for the action of anti-diabetic vanadium compounds.
about
Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical ReviewStructural and spectroscopic studies of a rare non-oxido V(v) complex crystallized from aqueous solutionCarcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes.Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study.The role of vanadium in biology.Perspectives for vanadium in health issues.Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells.Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride.VIVO complexes with antibacterial quinolone ligands and their interaction with serum proteins.Vanadium(V) complexes of a tripodal ligand, their characterisation and biological implications.
P2860
Q28068342-7EDC9CAA-0767-4138-9B0F-FF9F30196FC7Q33814092-F6A72249-D6DA-4384-A8CF-FBA4B055045FQ34506295-F39A667A-D918-48C6-ADA1-E447D6C02560Q35612899-3EDC21E9-C00E-4715-9DFA-9953C685B89DQ38327171-7C92D8A2-FBDE-49DC-B085-5F1B57A1ED9DQ38742665-C6ABB7CA-499B-4AA1-A614-7E8B19521252Q38747030-15F63DFD-C68D-44EE-8398-1D8155947631Q46346192-8F018EF6-0AC8-4106-9E26-CF31F8B3BD4EQ46390552-78233411-1000-4FE0-8F02-A14CF5879320Q46556968-7379F12D-7C7C-4EF4-883F-B2BC260E0204Q47720108-A36B47DA-4E2A-46C4-8089-7F92675BCC25Q50209449-2E08E604-17A0-459E-8E48-D2DDEBCAB9B7
P2860
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
@en
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
@nl
type
label
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
@en
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
@nl
prefLabel
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
@en
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
@nl
P2860
P50
P356
P1433
P1476
Structural and redox requirements for the action of anti-diabetic vanadium compounds.
@en
P2093
Giovanni Micera
Hiromu Sakurai
P2860
P304
P356
10.1039/C3DT52895B
P407
P577
2014-03-25T00:00:00Z